What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma

Update: 2025-01-15

Description

Dr Jennifer Crombie from Dana-Farber Cancer Institute, Prof Martin Hutchings from Copenhagen University Hospital, Dr Matthew Lunning from the University of Nebraska Medical Center, Dr Tycel Phillips from City of Hope and moderator Dr Jeremy S Abramson from Massachusetts General Hospital discuss recently updated data on the role of CAR T-cell therapy and bispecific antibodies in the management of diffuse large B-cell, mantle cell and follicular lymphoma. Produced by Research To Practice.

CME information and select publications here.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma

2025-01-1502:00:28

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Myelofibrosis

2025-01-1301:59:14

Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of Metastatic Breast Cancer

2025-01-1002:00:59

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia

2025-01-0801:26:59

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia

2025-01-0601:58:50

Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer

2025-01-0302:00:36

Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer

2024-12-2301:31:28

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma

2024-12-2001:57:10

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia

2024-12-1801:57:07

Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal Cancers

2024-12-1849:10

Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary Cancers

2024-12-1855:49

Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers

2024-12-1746:41

Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis

2024-12-1751:43

Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes

2024-12-1351:44

Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

2024-12-1348:03

5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 2

2024-12-1311:58

Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

2024-12-1058:47

Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer

2024-12-0459:42

Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria

2024-12-0301:46:37

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Multiple Myeloma

2024-11-2652:45

00:00

What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma

#box-pro-ellipsis-173697120133137{-webkit-line-clamp:2;}What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma

What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma

Research To Practice

What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma